胆红素与冠心病及炎性标记物hs-CRP相关性分析
[Abstract]:Objective to analyze whether total bilirubin level (TBil) is the protective factor of coronary heart disease (CHD) and its predictive value, and to explore the possible protective mechanism of coronary heart disease (CHD) by analyzing the relationship between total bilirubin and hs-CRP. Methods from October 2014 to October 2016, 180 patients with suspected angina pectoris of coronary heart disease and complete clinical data were selected. Age, sex, body mass index (BMI), hypertension, diabetes mellitus, smoking history, high density lipoprotein (high density lipoprotein,HDL) were collected. Low density lipoprotein (low density lipoprotein,LDL), total bilirubin (total bilirubin,TBil), hypersensitive C-reactive protein (high-sensitivity C-reaction protein,hs-CRP), alanine aminotransferase (alanine transaminase,ALT) and so on. Logistic regression analysis was used to investigate the correlation between TBil and coronary heart disease. The relationship between TBil and hs-CRP was analyzed by bivariate Pearson method, and the diagnostic value of TBil in coronary heart disease was discussed by drawing the (receiver operating characteristic curve,ROC curve of operating characteristic curve of subjects. Results (1) compared with the non-CHD group, the level of TBil in the CHD group was lower (P0.05). The results of binary Logistic regression analysis showed that TBil was an independent protective factor for coronary heart disease (P0. 001% 95 CI: 0.7380.922). (2) the linear analysis of bivariate Pearson showed that there was a negative correlation between TBil and hs-CRP level (r-0.367, P0.001); (3) by drawing the ROC curve, TBil correctly predicted that the threshold value of coronary heart disease was 10.35 umol / L, and the area under the maximum ROC curve was 0.739 (P0.01 ~ 95CI: 0.668 / 0.811). The sensitivity and specificity of TBil were 0.633 and 0.700 respectively. Conclusion TBil is an independent protective factor for coronary heart disease, low level TBil can be used as a predictor of coronary heart disease, TBil is negatively correlated with hs-CRP, suggesting that its anti-inflammatory effect may be one of its protective mechanisms for coronary heart disease. TBil10.35umol/L can be used as a defining indicator for the diagnosis of coronary heart disease.
【学位授予单位】:安徽医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R541.4
【参考文献】
相关期刊论文 前8条
1 樊鹏燕;程英;宫京梅;;血清胆红素水平与冠心病病变程度的相关性研究[J];宁夏医学杂志;2016年11期
2 Nancy Gupta;Tavankit Singh;Rahul Chaudhary;Sushil K Garg;Gurprataap Singh Sandhu;Varun Mittal;Rahul Gupta;Roxana Bodin;Sachin Sule;;Bilirubin in coronary artery disease:Cytotoxic or protective?[J];World Journal of Gastrointestinal Pharmacology and Therapeutics;2016年04期
3 张明明;谢翔;马依彤;;血清胆红素与冠心病关系的研究进展[J];中国心血管杂志;2016年02期
4 钟志娟;许坚锋;陈红涛;李冬梅;郭国威;;冠心病患者超敏C反应蛋白及总胆红素检测的临床意义[J];检验医学与临床;2012年20期
5 张晓慧;李光韬;张卓莉;;C反应蛋白与超敏C反应蛋白的检测及其临床意义[J];中华临床免疫和变态反应杂志;2011年01期
6 许岭翎;;2010年中国2型糖尿病防治指南解读[J];中国社区医师;2011年07期
7 任国庆;陈义坤;张浩;;早发冠心病的危险因素及其冠状动脉病变特点[J];中国动脉硬化杂志;2009年11期
8 姚友杰;杨敏华;许炳灿;王景峰;;血清尿酸、胆红素和超敏C反应蛋白与冠状动脉病变程度关系研究[J];中国介入心脏病学杂志;2008年06期
,本文编号:2313795
本文链接:https://www.wllwen.com/yixuelunwen/xxg/2313795.html